常温体外循环机市场：依应用、器官类型、最终用户、灌注类型、组件、地区划分

预计到 2026 年，常温灌注机市场价值将达到 20.5 亿美元，到 2033 年将达到 65.7 亿美元，2026 年至 2033 年的复合年增长率为 18.11%。

全球常温机械灌注市场代表着器官保存技术的变革性进步，它透过在储存和运输过程中将器官维持在生理温度下，从根本上革新了移植医学。与传统的冷藏方法不同，常温机械灌注系统能够在体温（37 度C）下保存器官，同时提供持续的含氧血液供应，显着延长器官的存活时间，并改善移植效果。这项创新技术解决了器官移植领域的关键挑战，包括器官短缺、保存品质和长期储存等问题，从而扩大了捐赠者来源，并有助于提高受者的生存率。

该市场涵盖先进的灌注设备、专用灌注液、监测系统以及为全球医疗机构提供支援的完善服务网路。随着末期器官疾病的增加，全球对器官移植的需求日益增长，常温机械灌注技术已成为弥合医疗系统中器官供应与患者需求之间差距的关键解决方案。该技术已被证实能够评估移植前器官功能、减轻缺血再灌流伤害并实现体外器官修復，使其成为现代移植通讯协定的重要组成部分，推动了市场显着增长，并吸引了医疗设备製造商和医疗服务提供者的大量投资。

市场动态

全球常温灌注机市场正经历强劲成长，主要得益于多种有利因素。其中一个关键驱动因素是全球可移植器官的严重短缺，这导致对能够最大限度利用器官并延长器官保存时间的技术需求迫切。肝硬化、肾衰竭和心臟病等慢性疾病的增加，显着扩大了需要器官移植的患者数量。此外，全球人口老化也加剧了器官需求的成长，并促使捐赠者标准更加广泛。灌注系统的技术进步，例如自动化监测、即时器官评估功能以及灌注液生物相容性的提高，正在改善临床疗效，并促进其在移植中心的应用。

越来越多的临床证据表明，与冷冻保存方法相比，器官移植具有更优的器官保存效果、更低的原发性功能障碍率和更高的长期移植存活率，这推动了医生对移植的信心，并促使医疗机构采用移植技术。

然而，市场限制因素包括灌注设备的大量资本投入、持续的营运成本（包括专用灌注液和技术专长）以及因地区而异的复杂设备核准监管流程。某些医疗保健系统对保险覆盖范围的限制也构成了广泛应用的经济障碍，而对专业培训和技术支援的需求则给小规模移植中心带来了实施方面的挑战。儘管存在这些限制因素，但随着应用范围从肝臟和肾臟保存扩展到心臟、肺臟和胰腺灌注；由于保存技术的进步，扩大标准供体器官的接受度不断提高；以及新兴市场医疗基础设施的建设（移植项目正在迅速发展），市场仍蕴藏着巨大的机会。

本报告的主要特点

• 本报告对全球常温灌注机市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和復合年增长率。
• 它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
• 全球常温灌注机市场的主要企业会根据以下参数进行概况介绍，例如公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告提供的见解将使负责人和公司经营团队能够就未来的产品发布、产品更新、市场扩张和行销策略做出明智的决策。
• 《全球常温灌注机市场》报告针对该产业的各类相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过各种策略矩阵更轻鬆地做出决策，这些矩阵用于分析全球常温灌注机市场。

目录

第一章 分析目标与先决条件

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监管与趋势分析

• 市场动态
• 司机
• 抑制因素
• 机会
• 影响分析
• 重大进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特五力分析
• 企业合併情景
• 产业趋势

4. 全球常暖体外循环机市场依应用领域划分（2021-2033 年）

• 器官保存
• 器官修復
• 器官移植

5. 全球常温体外循环机市场（依器官类型划分）（2021-2033 年）

• 肾
• 肝
• 心
• 肺
• 胰臟

6. 全球常温灌注机市场（依最终用户划分）（2021-2033 年）

• 医院、手术中心
• 器官移植中心
• 研究所
• 器官获取组织

7. 全球常温灌注机市场（依灌注类型划分）（2021-2033 年）

• 低温机械灌注
• 室温机械灌注

8. 全球常温灌注机市场（依组件划分）（2021-2033 年）

• 耗材（试管、溶液组、过滤器）
• 设备（灌注设备、感测器）
• 软体（监控和数据分析系统）

第九章 全球室温机械灌注市场：按地区划分（2021-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中非

第十章 竞争格局

• TransMedics Group Inc
• Organ Recovery Systems
• XVIVO Perfusion AB
• OrganOx Limited
• Getinge（Paragonix Technologies）
• Bridge to Life Ltd
• Waters Medical Systems
• Preservation Solutions Inc
• Institut Georges Lopez SA
• EBERS Medical Technology SL
• Shenzhen Lifotronic Technology Co Ltd
• Genus Medical Technologies LLC
• Terumo Corporation
• Medtronic plc
• LivaNova Plc

第十一章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map (COM)

第十二章 参考文献与分析方法

• 参考
• 分析方法
• 关于 Coherent Market Insights

Normothermic Machine Perfusion Market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 6.57 Bn by 2033, expanding at a compound annual growth rate (CAGR) of 18.11% from 2026 to 2033.

The global normothermic machine perfusion market represents a transformative advancement in organ preservation technology, fundamentally revolutionizing transplantation medicine by maintaining organs at physiological temperatures during storage and transport. Unlike traditional cold storage methods, normothermic machine perfusion systems preserve organs at body temperature (37°C) while providing continuous oxygenated blood flow, significantly extending organ viability and improving transplantation outcomes. This innovative technology addresses critical challenges in organ transplantation, including organ shortage, preservation quality, and extended storage times, thereby expanding the donor pool and enhancing recipient survival rates.

The market encompasses sophisticated perfusion devices, specialized perfusion solutions, monitoring systems, and comprehensive service networks that support healthcare institutions worldwide. As healthcare systems globally face increasing demand for organ transplants amid growing prevalence of end-stage organ diseases, normothermic machine perfusion technology emerges as a crucial solution bridging the gap between organ availability and patient needs. The technology's proven ability to assess organ functionality before transplantation, reduce ischemia-reperfusion injury, and enable ex-vivo organ repair positions it as an indispensable component of modern transplantation protocols, driving substantial market growth and attracting significant investment from medical device manufacturers and healthcare providers.

Market Dynamics

The global normothermic machine perfusion market experiences robust growth driven by multiple compelling factors, with the primary driver being the critical shortage of transplantable organs worldwide, creating urgent demand for technologies that maximize organ utilization and extend preservation periods. Increasing prevalence of chronic diseases such as liver cirrhosis, kidney failure, and heart disease significantly amplifies the patient population requiring organ transplants, while aging demographics globally contribute to both increased organ demand and expanded donor criteria acceptance. Technological advancements in perfusion systems, including automated monitoring, real-time organ assessment capabilities, and improved biocompatibility of perfusion solutions, enhance clinical outcomes and drive adoption among transplant centers.

Growing clinical evidence demonstrating superior organ preservation, reduced primary non-function rates, and improved long-term graft survival compared to cold storage methods strengthens physician confidence and institutional adoption.

However, market restraints include substantial capital investment requirements for perfusion equipment, ongoing operational costs including specialized perfusion fluids and technical expertise, and complex regulatory pathways for device approval across different regions. Limited reimbursement coverage in certain healthcare systems creates financial barriers for widespread adoption, while the need for specialized training and technical support infrastructure poses implementation challenges for smaller transplant centers. Despite these constraints, significant opportunities emerge from expanding applications beyond liver and kidney preservation to include heart, lung, and pancreas perfusion, growing acceptance of extended criteria donor organs through improved preservation techniques, and increasing healthcare infrastructure development in emerging markets where transplantation programs are expanding rapidly.

Key Features of the Study

• This report provides in-depth analysis of the global normothermic machine perfusion market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global normothermic machine perfusion market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include TransMedics Group Inc, Organ Recovery Systems, XVIVO Perfusion AB, OrganOx Limited, Getinge (Paragonix Technologies), Bridge to Life Ltd, Waters Medical Systems, Preservation Solutions Inc, Institut Georges Lopez SA, EBERS Medical Technology SL, Shenzhen Lifotronic Technology Co Ltd, Genus Medical Technologies LLC, Terumo Corporation, Medtronic plc, and LivaNova Plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global normothermic machine perfusion market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global normothermic machine perfusion market

Market Segmentation

• Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Organ Preservation
  • Organ Reconditioning
  • Organ Transplantation
• Organ Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
• End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals and Surgical Centers
  • Organ Transplantation Centers
  • Research Laboratories
  • Organ Procurement Organizations
• Type of Perfusion Insights (Revenue, USD Bn, 2021 - 2033)
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
• Component Insights (Revenue, USD Bn, 2021 - 2033)
  • Consumables (Tubing, Solution Kits, Filters)
  • Devices (Perfusion Machines, Sensors)
  • Software (Monitoring and Data Analysis Systems)
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • TransMedics Group Inc
  • Organ Recovery Systems
  • XVIVO Perfusion AB
  • OrganOx Limited
  • Getinge (Paragonix Technologies)
  • Bridge to Life Ltd
  • Waters Medical Systems
  • Preservation Solutions Inc
  • Institut Georges Lopez SA
  • EBERS Medical Technology SL
  • Shenzhen Lifotronic Technology Co Ltd
  • Genus Medical Technologies LLC
  • Terumo Corporation
  • Medtronic plc
  • LivaNova Plc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Normothermic Machine Perfusion Market, By Application
  • Global Normothermic Machine Perfusion Market, By Organ Type
  • Global Normothermic Machine Perfusion Market, By End User
  • Global Normothermic Machine Perfusion Market, By Type of Perfusion
  • Global Normothermic Machine Perfusion Market, By Component
  • Global Normothermic Machine Perfusion Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Normothermic Machine Perfusion Market, By Application, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Organ Preservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Organ Reconditioning
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Organ Transplantation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Normothermic Machine Perfusion Market, By Organ Type, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Kidney
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Liver
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Heart
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Lung
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Pancreas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Normothermic Machine Perfusion Market, By End User, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals and Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Organ Transplantation Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Organ Procurement Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Normothermic Machine Perfusion Market, By Type of Perfusion, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hypothermic Machine Perfusion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Normothermic Machine Perfusion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Normothermic Machine Perfusion Market, By Component, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Consumables (Tubing, Solution Kits, Filters)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Devices (Perfusion Machines, Sensors)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Software (Monitoring and Data Analysis Systems)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Normothermic Machine Perfusion Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• TransMedics Group Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Organ Recovery Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• XVIVO Perfusion AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• OrganOx Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Getinge (Paragonix Technologies)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bridge to Life Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Waters Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Preservation Solutions Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Institut Georges Lopez SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EBERS Medical Technology SL
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Shenzhen Lifotronic Technology Co Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genus Medical Technologies LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LivaNova Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us